AstraZeneca Tagrisso, Pfizer Xalkori Stand Out Among US FDA’s Single-Arm Oncology Approvals, JAMA Suggests

 
• By Bridget Silverman
  
Photo of an Asian male exercising with dumbbells and doing a single shoulder press over dark background.
How strong can the data in a single arm be?

More from Clinical Trials

More from R&D